Revenues | 12.6M |
Costs and expenses: | |
Cost of sales | 7.28M |
Selling, general and administrative | 5.79M |
Gain on revaluation of ACT liability | |
Research and development | 1.3M |
[OperatingExpenses] | |
Operating income (loss) | -2.88M |
Interest expense | 0 |
Interest income | 5K |
Other expense | -254K |
Income before income taxes | -3.13M |
Income tax (expense) benefit | 114K |
Net income (loss) | -3.02M |
Net income (loss) per common share: | |
Basic (in Dollars per share) | -0.13 |
Diluted (in Dollars per share) | -0.13 |
Weighted-average number of common shares outstanding: | |
Basic (in Shares) | 23.45M |
Diluted (in Shares) | 23.45M |